Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases.

Observed Findings

• CoQ10 exists in reduced and oxidized forms in mitochondria and cell membranes, with high concentrations in metabolically active organs (liver, heart, kidneys).
• Low blood levels of CoQ10 show inverse correlation with several disease conditions, including neurodegenerative and muscular disorders.
• CoQ10 demonstrates antioxidant and anti-inflammatory properties capable of preventing free radical damage and inhibiting inflammatory signaling.
• CoQ10 is involved in mitochondrial oxidative phosphorylation (OXPHOS), the primary mechanism of cellular energy production.
• Chronic fatigue syndrome is identified as a degenerative muscle disorder potentially responsive to CoQ10 supplementation.

Inferred Conclusions

• CoQ10 supplementation may represent a viable preventive strategy for diseases involving mitochondrial dysfunction and neuronal/muscular degeneration, including ME/CFS.
• CoQ10 could serve as an adjuvant therapy alongside conventional treatments for multiple disease conditions.
• The relationship between serum CoQ10 deficiency and disease states suggests potential therapeutic benefit in restoring adequate levels.
• Further clinical investigation is warranted to establish efficacy and optimal dosing across disease populations.

Remaining Questions